Key Takeaways
- Yes — the Mental Health Parity and Addiction Equity Act (MHPAEA) requires most insurance to cover addiction treatment at the same level as medical care.
- The ACA classifies substance use disorder treatment as an essential health benefit — all marketplace plans must cover it.
- Medicaid covers addiction treatment in all 50 states. Medicare covers detox, inpatient, and outpatient treatment.
- Insurance still creates barriers through pre-authorization requirements, network restrictions, and step-therapy requirements — all of which can be navigated.
- Our specialists verify your specific benefits free and handle pre-authorization on your behalf. Call (844) 561-0606.
In This Article
The most common reason people delay or avoid addiction treatment is the belief that they can’t afford it. In the majority of cases, this belief is wrong. Two landmark federal laws — MHPAEA and the ACA — have made addiction treatment coverage a legal requirement for most Americans with health insurance.
What MHPAEA Actually Requires
The Mental Health Parity and Addiction Equity Act (2008) requires health insurance plans that cover mental health and substance use disorder (SUD) benefits to provide that coverage at the same level as medical and surgical benefits. This means:
- If your plan covers unlimited physical therapy visits, it cannot cap addiction counseling visits
- If your plan doesn’t require pre-authorization for a broken arm surgery, it cannot require it for detox (or must apply the same standards)
- Your plan cannot charge higher copays or deductibles for SUD treatment than for medical treatment
- Your plan cannot impose more restrictive treatment limitations (day limits, visit limits) on SUD care than on comparable medical care
MHPAEA Has Teeth — But You Have to Use Them
Insurers frequently violate MHPAEA in ways that are not obvious. A 2023 report found widespread parity violations across major insurers. If your insurance is denying addiction treatment while covering comparable medical care, you have legal grounds for appeal. Our specialists can help you identify parity violations.
ACA Essential Health Benefits
The Affordable Care Act classifies substance use disorder treatment as one of 10 essential health benefits that all marketplace plans and Medicaid expansion plans must cover. This means:
- All plans sold on Healthcare.gov must cover addiction treatment
- Medicaid expansion plans must cover addiction treatment
- No plan can impose annual or lifetime dollar limits on SUD coverage
- Coverage must include the full continuum: detox, inpatient, PHP, IOP, outpatient, and MAT medications
Medicaid, Medicare & TRICARE
Medicaid is the single largest payer for addiction treatment in the US, covering detox, residential rehab, MAT (including methadone through OTPs and buprenorphine), PHP, IOP, and outpatient counseling in all 50 states. Low-income adults in expansion states (38 states + DC) typically qualify at little to no cost.
Medicare covers inpatient hospital detox under Part A, outpatient SUD treatment under Part B, physician-prescribed buprenorphine under Part B, methadone through licensed OTPs under a bundled payment, and MAT medications under Part D pharmacy benefits.
TRICARE covers active duty service members, veterans (through VA), and eligible family members. TRICARE covers detox, inpatient rehab, IOP, and MAT. VA addiction treatment programs are available to all eligible veterans at low or no cost.
Common Insurance Barriers & How to Overcome Them
| Barrier | What It Means | How to Overcome It |
|---|---|---|
| Pre-authorization | Insurer requires approval before admission | Our specialists submit pre-auth documentation on your behalf — same-day in many cases |
| Out-of-network | Facility doesn’t have a contract with your plan | We identify in-network programs before any referral. Out-of-network may still be partially covered. |
| Step therapy | Insurer requires lower level of care first | Clinical documentation of medical necessity can override step therapy requirements |
| Concurrent review | Insurer reviews necessity during your stay | Treatment centers handle this — our network programs are experienced with concurrent review |
| Day/visit limits | Plan limits total treatment days | May violate MHPAEA — we help identify potential parity violations for appeal |
What to Do If Insurance Denies Coverage
A denial is not the end. Insurance companies deny claims that should be covered — frequently — because they know many people won’t appeal. Steps to take:
- Get the denial in writing — they are required to provide a written explanation including the specific criteria used to deny
- Request an internal appeal — you have the right to an internal appeal within 180 days of denial under ACA rules
- Request independent external review — if the internal appeal is denied, you can request an independent external review conducted by a neutral third party
- File a parity complaint — if the denial appears to violate MHPAEA, file a complaint with your state insurance commissioner and the Department of Labor (for employer plans)
- Call our helpline — our specialists have experience navigating denials and can help you identify the strongest grounds for appeal
How to Verify Your Benefits in Minutes
Don’t guess at your coverage — verify it. Our specialists contact your insurance company directly, verify your addiction treatment benefits in real time, and provide a clear plain-language summary of what’s covered and what to expect out of pocket. This service is completely free and takes 10–20 minutes.
Verify Your Insurance Coverage Free
No obligation. No commitment to treatment. Just clarity on what your plan covers — so you can make an informed decision.
Sources
- CMS. (2023). Mental Health Parity and Addiction Equity Act (MHPAEA).
- SAMHSA. (2023). Insurance Coverage of Mental Health and Substance Use Disorder Services.
- U.S. Departments of Health, Labor & Treasury. (2023). Report to Congress: MHPAEA Parity Assessment.
- KFF. (2024). Mental Health Parity: What Is It and How Is It Working?
Addiction Helpline America Clinical Team
All content reviewed by licensed addiction medicine specialists following SAMHSA, NIDA, and ASAM guidelines. Learn about our editorial process.